Tanimoto Sarina
SEC CIK 1951291 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Chief Medical Off, 10% | 1.29M | — | $23.80M | 31 | 2022-11-08 | 2025-08-19 |
Most active insiders at SPRY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chakma Justin | Chief Business Off | — | $1.48M |
| 2 | Karas Eric | Chief Commercial Off | — | $250.0K |
| 3 | Dorsey Brian | COO | — | $190.1K |
| 4 | Fitzpatrick Alexander A | CLO | — | $33.5K |
| 5 | Shah Pratik | Dir | — | — |
Tanimoto Sarina made no open-market trades at SPRY in the last 12 months.
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-08-21 | 2025-08-19+ | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $14.08 | -50.0K | 1.29M | -4% | -$703.8K |
| MI | 2024-12-19 | 2024-12-17 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $11.67 | -100.0K | 1.10M | -8% | -$1.17M |
| MI | 2024-12-11 | 2024-12-10 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $13.16 | -100.0K | 1.15M | -8% | -$1.32M |
| DM | 2024-12-09 | 2024-12-06 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $4.67 | +25.7K | 3.43M | +0.8% | +$119.9K |
| DI | 2024-12-09 | 2024-12-06 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $8.42 | +11.9K | 4.33M | +0.3% | +$100.0K |
| MI | 2024-11-21 | 2024-11-19 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $13.95 | -100.0K | 1.35M | -7% | -$1.40M |
| MI | 2024-11-14 | 2024-11-12 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $16.85 | -100.0K | 1.30M | -7% | -$1.68M |
| MI | 2024-10-17 | 2024-10-15 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $14.88 | -100.0K | 1.40M | -7% | -$1.49M |
| MI | 2024-10-10 | 2024-10-08 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $13.83 | -100.0K | 1.35M | -7% | -$1.38M |
| MI | 2024-09-19 | 2024-09-17 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $12.93 | -100.0K | 1.45M | -6% | -$1.29M |
| MI | 2024-09-12 | 2024-09-10 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $11.50 | -100.0K | 1.40M | -7% | -$1.15M |
| MI | 2024-08-21 | 2024-08-20 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $15.03 | -100.0K | 1.50M | -6% | -$1.50M |
| MI | 2024-08-15 | 2024-08-13 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $12.48 | -100.0K | 1.45M | -6% | -$1.25M |
| MI | 2024-07-18 | 2024-07-16 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $11.40 | -100.0K | 1.60M | -6% | -$1.14M |
| MI | 2024-07-11 | 2024-07-09 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.62 | -100.0K | 1.65M | -6% | -$962.0K |
| MI | 2024-06-13 | 2024-06-11+ | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.14 | -100.0K | 1.59M | -6% | -$913.9K |
| MI | 2024-05-16 | 2024-05-14+ | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.06 | -100.0K | 1.64M | -6% | -$905.6K |
| MI | 2024-05-09 | 2024-05-07 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.34 | -100.0K | 1.80M | -5% | -$934.0K |
| DM | 2024-04-24 | 2024-04-23 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $1.06 | +131.0K | 3.36M | +4% | +$139.0K |
| DMI | 2024-04-22 | 2024-04-19 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $1.06 | +188.5K | 4.25M | +5% | +$200.0K |
| MI | 2024-04-17 | 2024-04-16 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.28 | -100.0K | 1.65M | -6% | -$928.0K |
| MI | 2024-04-10 | 2024-04-09 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.28 | -100.0K | 1.90M | -5% | -$928.0K |
| MI | 2024-03-26 | 2024-03-22+ | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.12 | -97.6K | 2.00M | -5% | -$890.0K |
| MI | 2024-03-21 | 2024-03-19+ | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.03 | -2,390 | 1.75M | -0.1% | -$21.6K |
| MI | 2024-03-15 | 2024-03-13+ | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.14 | -100.0K | 1.74M | -5% | -$913.5K |
| MI | 2024-03-01 | 2024-02-29 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.01 | -3,782 | 2.05M | -0.2% | -$34.1K |
| MI | 2024-02-28 | 2024-02-26+ | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.02 | -99.5K | 1.75M | -5% | -$897.3K |
| DMI | 2024-01-04 | 2023-05-17 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief Medical Off, 10% | G - Gift | $0.00 | +1.05M | 1.05M | New | $0 |
| D | 2024-01-04 | 2023-05-17 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief Medical Off, 10% | G - Gift | $0.00 | -1.05M | 3.28M | -24% | $0 |
| DMI | 2022-11-10 | 2022-11-08 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief Medical Off, 10% | A - Grant | — | +7.87M | 1.77M | New | — |
| D | 2022-11-10 | 2022-11-08 | SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | Chief Medical Off, 10% | A - Grant | — | +4.33M | 4.33M | New | — |
Purchase Sale Sale after option exercise All abbreviations